Skip to content
esmolol

Structure via PubChem · Public domain (PubChem)

EntityQ418139· pop 23· linked from 111 articles

Also known as (±)-esmolol, (±)-methyl p-(2-hydroxy-3-(isopropylamino)propoxy)hydrocinnamate, methyl p-(2-hydroxy-3-(isopropylamino)propoxy)hydrocinnamate, 3-[4-(2-hydroxy-3-isopropylamino-propoxy)-phenyl]-propionic acid methyl ester, methyl 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)benzenepropanoate

Esmolol, sold under the brand name Brevibloc, is a cardio selective beta1 receptor blocker with rapid onset, a very short duration of action, and no significant intrinsic sympathomimetic or membrane stabilising activity at therapeutic dosages.

Chemical data

Formula
C16H25NO4
Molecular weight
295.37 g/mol
IUPAC name
methyl 3-[4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]propanoate
SMILES
CC(C)NCC(COC1=CC=C(C=C1)CCC(=O)OC)O
InChIKey
AQNDDEOPVVGCPG-UHFFFAOYSA-N
XLogP
1.9
Polar surface area
67.8 Ų
H-bond donors
2
H-bond acceptors
5
Formal charge
0

via PubChem

Wikidata facts

Mass
295.178
Show 4 more facts
chemical formula
C₁₆H₂₅NO₄
canonical SMILES
CC(C)NCC(COC1=CC=C(C=C1)CCC(=O)OC)O
Commons category
Esmolol
defined daily dose
2.5
Sources (4)

via Wikidata · CC0

~4 min read

Article

6 sections
Contents
  • Medical uses
  • Pharmacology
  • Pharmacodynamics
  • Pharmacokinetics
  • Chemistry
  • References

{{Drugbox | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 412885041 | image = Esmolol structure.svg | image_class = skin-invert-image

| tradename = Brevibloc | Drugs.com = | pregnancy_AU = C | pregnancy_category = | routes_of_administration = Intravenous | ATC_prefix = C07 | ATC_suffix = AB09

Connections

Categories